Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy

Published:2020-05-18 Issue:14 Volume:9 Page:4962-4970
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Dharmapuri Sirish¹^ORCID,Özbek Umut²,Lin Jung‐Yi²^ORCID,Sung Max¹,Schwartz Myron³,Branch Andrea D.⁴,Ang Celina¹

Affiliation:

1. Department of Medicine Division of Medical Oncology Tisch Cancer InstituteIcahn School of Medicine at Mount Sinai New York NY USA

2. Department of Population Health Science and Policy Tisch Cancer InstituteIcahn School of Medicine at Mount Sinai New York NY USA

3. Department of Surgery Recanati/Miller Transplant InstituteIcahn School of Medicine at Mount Sinai New York NY USA

4. Department of Medicine Division of Liver Disease Icahn School of Medicine at Mount Sinai New York NY USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3135

Reference32 articles.

1. High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

4. Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).

5. OPDIVO [package insert].Princeton NJ:Bristol‐Myers Squibb Company;2019.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of NLR, PLR, SII, and dNLR in Urothelial Bladder Cancer Following Radical Cystectomy;Clinical Genitourinary Cancer;2024-10

2. Dynamic Changes of Neutrophil-to-Lymphocyte Ratio on Predicting Response of Immune Checkpoint Inhibitors Plus Targeted Therapies for Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-08

3. Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma;Frontiers in Oncology;2024-06-27

4. Efficacy of first-line chemotherapy based on primary site of tumor versus etoposide-platinum in advanced gastroenteropancreatic neuroendocrine carcinoma;Journal of Gastrointestinal Oncology;2024-06

5. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation;Cancers;2024-05-30